The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors
Mathieu Desaunay,
Edwige Voisset,
Sebastien Letard,
Philippe Roche,
Paulo De Sepulveda
Affiliations
Mathieu Desaunay
Centre de Recherche en Cancérologie de Marseille, CRCM, Marseille, France; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France; Signaling, Hematopoiesis and Mechanism of Oncogenesis Lab, Marseille, France
Edwige Voisset
Centre de Recherche en Cancérologie de Marseille, CRCM, Marseille, France; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France; Signaling, Hematopoiesis and Mechanism of Oncogenesis Lab, Marseille, France
Sebastien Letard
Centre de Recherche en Cancérologie de Marseille, CRCM, Marseille, France; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France; Signaling, Hematopoiesis and Mechanism of Oncogenesis Lab, Marseille, France
Philippe Roche
Centre de Recherche en Cancérologie de Marseille, CRCM, Marseille, France; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France; High Throughput Screening (HiTS) Facility, Marseille, France
Paulo De Sepulveda
Correspondence Address correspondence to: Paulo De Sepulveda, PhD, Cancer Research Centre Marseille, 27 Boulevard Lei Roure, 13009 Marseille, France.; Centre de Recherche en Cancérologie de Marseille, CRCM, Marseille, France; Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France; Signaling, Hematopoiesis and Mechanism of Oncogenesis Lab, Marseille, France; OPALE Carnot Institute, Paris, France
